TAK-748

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameTAK-748
Drug Alias NameAAV8.ss-3xCRM8-TTR-FIX-R338LoptF9 gene therapy (Shire)AAV vector-8 based gene therapy (Shire)SHP-648TAK-748
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionCoagulation factor IX stimulants
TargetsCoagulation factor IX
Therapy Area/IndicationsHemophilia B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesEuropeUnited Kingdom
CombinationsNo
Global Highest StatusSuspended
Highest Status in ChinaN/A
Originator CompaniesShire
China Registration ClassN/A

Develop Information

Active CompaniesShire
Inactive CompaniesN/A
Active IndicationsHemophilia B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A